Article Sidebar

PDF
Date Published: 15/06/2023
Abstract Views: 794
Views PDF: 326
DOI: https://doi.org/10.51298/vmj.v527i1.5637
Issue
Vol. 527 No. 1 (2023)
Section
Các bài báo
How to Cite
Nguyễn, P. H. ., Phạm , T. T. ., Dương , X. C. ., & Võ , T. M. H. . (2023). THE STUDY OF TREATMENT COSTS FOR OUTPATIENT ASTHMA PATIENTS WITH HEALTH INSURANCE AT CAN THO TUBERCULOSIS ANG LUNG DISEASE HOSPITAL IN 2020-2021. Vietnam Medical Journal, 527(1). https://doi.org/10.51298/vmj.v527i1.5637

THE STUDY OF TREATMENT COSTS FOR OUTPATIENT ASTHMA PATIENTS WITH HEALTH INSURANCE AT CAN THO TUBERCULOSIS ANG LUNG DISEASE HOSPITAL IN 2020-2021

Phục Hưng Nguyễn1, Thanh Tuấn Phạm 2, Xuân Chữ Dương 1, Thị Mỹ Hương Võ 1,
1 Can Tho University of Medicine - Pharmacy
2 Domesco company

Main Article Content

Abstract

Objectives: To analyze costs and some factors related to treatment costs for patient outpatient asthmatics with health insurance at Can Tho Tuberculosis and Lung Disease Hospital in 2020-2021. Methods: a cross-sectional descriptive study on prescriptions and treatment costs in 142 medical records of patients diagnosed and treated as outpatients with medical insurance. at Can Tho Tuberculosis and Lung Disease Hospital from June 2020 to June 2021. Results: cost and structure of costs for outpatients: the average cost/person/treatment is VND 501,600. The total cost of the patient's medical services is VND 71,227,172. The highest proportion is drug costs (59.20%). In drug costs, the cost for the group of drugs in the form of a combination of bronchodilators and corticosteroids accounted for 76.26%. Insurance costs accounted for 81.87%. In outpatient treatment, there is a relationship between cost, cost structure and age group, level of asthma control, number of days of treatment and level of health insurance coverage. Conclusion: As a reference to help experts have an overview of the cost of asthma treatment, helping asthmatics reduce the economic burden of disease treatment.

Article Details

Keywords

Cost, Asthma, Outpatient

References

1. Nguyễn Năng An (2007), Dị ứng miễn dịch lâm sàng, Nhà xuất bản Y học, Hà Nội.
2. Bộ Y tế (2007), Dược lý học tập 2, Nhà xuất bản Y học, Hà Nội.
3. Bộ Y tế (2020), Quyết định số 1851/QĐ-BYT về việc ban hành Hướng dẫn chẩn đoán và điều trị hen phế quản người lớn và trẻ em 12 tuổi, Hà Nội, tr. 15-20.
4. Trần Thị Minh Tâm (2019), Phân tích chi phí điều trị hen phế quản tại bệnh viện quận Phú Nhuận giai đoạn 2014-2018, Luận án Chuyên Khoa II, Trường Đại học Y Dược thành phố Hồ Chí Minh.
5. Bavbek S., Mungan D., Türktaş H., Mısırlıgil Z., Gemicioğlu B., ADVISE Study Group. (2011), A cost-of-illness study estimating the direct cost per asthma exacerbation in Turkey, Respir Med, 105(4), pp. 541-548.
6. Costa E., Caetano R., Werneck G. L., Bregman M., Araújo D. V., Rufino R. (2018), Estimated cost of asthma in outpatient treatment: a real-world study, Rev Saude Publica, 52, pp. 1-10.
7. de Llano L. A. P., Villoro R., Merino M., Neira M. D. C. G., Muñiz C., Hidalgo Á. (2016), Cost Effectiveness of Outpatient Asthma Clinics, Arch Bronconeumol, 52 (4), pp. 196-203.
8. Global Initiative for Asthma (2020), Global Strategy for Asthma Management and Prevention.
9. Sharifi L., Dashti R., Pourpak Z., Fazlollahi M. R., Movahedi M., Chavoshzadeh Z., Moin M. (2018), Economic Burden of Pediatric Asthma: Annual Cost of Disease in Iran, Iran J Public Health, 47(2), pp. 256-263.
10. Tay T. R., Wong H. S., Ihsan R., Toh H. P., Choo X., Tee A. K. (2017), Comparison of the proportion and healthcare utilisation of adult patients with uncontrolled severe asthma versus non-severe asthma seen in a Southeast Asian, Health Burden of Severe Asthma, 46(6), pp. 217-228.